Welcome to the Young Scientists

Young Scientist Vaccine Innovation Award

YSVIAESWI is pleased to launch the 3rd edition of the Young Scientist Vaccine Innovation Award.

The Young Scientist Vaccine Innovation Award is an award supported by CSL Seqirus recognising exceptional research by a promising young scientist in the field of influenza vaccine development.

The Young Scientist Vaccine Innovation Award Winner will receive:

  • a cash prize of €10,000
  • an invitation to speak at the Ninth ESWI Conference hybrid edition, 17- 20 September 2023

Are you eligible?

  • Applicants must have a PhD for no longer than 7 years at the time of the application
  • Special considerations (for example maternity / paternity leave) are taken into account
  • Applicants should submit an executive summary report of their work as well as a proof of status in the form of an official university certificate or letter, which is signed by the supervisor / departmental head

How to apply?

  • Download the Application form
  • Submit the document no later than February 28th 2023 to f[email protected]
File Type Size
Application-form_ESWI-AWARDS-2023.docx Microsoft Office - OOXML - Word Document 230.8 KB

Previous winners

The winner of the first edition of the award is Dr. Kirsty Short, University of Queensland, Australia. She received her award at the 7th ESWI Influenza Conference virtual edition (6-9 December 2020).

Kirsty Short
Kirsty Short
School of Chemistry and Molecular Biosciences, University of Queensland, Australia

The Young Scientist Innovative Award played a very important role in building my international profile, as well as providing financial support to enable my group to start a new area of research.

Kirsty Short

The second winner of the award is Dr. Nicholas Wu, University of Illinois, USA. He received the prize at the virtual 8th ESWI Influenza Conference (4-7 December 2021).

I am humbly honored to receive the Young Scientist Innovative Award, which is an important milestone of my career and gives me confidence to continue pursuing my research interests.
Nicholas Wu